HomeCompareBZLYF vs MRK

BZLYF vs MRK: Dividend Comparison 2026

BZLYF yields 2.04% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BZLYF wins by $69.09M in total portfolio value· pulled ahead in Year 2
10 years
BZLYF
BZLYF
● Live price
2.04%
Share price
$16.79
Annual div
$0.34
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.15M
Annual income
$63,184,975.44
Full BZLYF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BZLYF vs MRK

📍 BZLYF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBZLYFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BZLYF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BZLYF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BZLYF
Annual income on $10K today (after 15% tax)
$172.98/yr
After 10yr DRIP, annual income (after tax)
$53,707,229.12/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, BZLYF beats the other by $53,698,900.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BZLYF + MRK for your $10,000?

BZLYF: 50%MRK: 50%
100% MRK50/50100% BZLYF
Portfolio after 10yr
$34.60M
Annual income
$31,597,386.79/yr
Blended yield
91.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BZLYF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
2.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BZLYF buys
0
MRK buys
0
No recent congressional trades found for BZLYF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBZLYFMRK
Forward yield2.04%2.76%
Annual dividend / share$0.34$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$69.15M$56.8K
Annual income after 10y$63,184,975.44$9,798.13
Total dividends collected$68.67M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BZLYF vs MRK ($10,000, DRIP)

YearBZLYF PortfolioBZLYF Income/yrMRK PortfolioMRK Income/yrGap
1$11,107$407.01$11,206$366.19$99.00MRK
2← crossover$12,729$844.99$12,650$502.35+$79.00BZLYF
3$15,431$1,810.14$14,407$694.19+$1.0KBZLYF
4$20,612$4,101.40$16,585$967.82+$4.0KBZLYF
5$32,296$10,240.44$19,342$1,363.89+$13.0KBZLYF
6$64,547$29,990.40$22,913$1,947.19+$41.6KBZLYF
7$181,101$112,036.45$27,662$2,823.89+$153.4KBZLYF
8$781,340$587,561.89$34,159$4,173.35+$747.2KBZLYF
9$5,574,289$4,738,254.55$43,337$6,308.80+$5.53MBZLYF
10$69,149,464$63,184,975.44$56,776$9,798.13+$69.09MBZLYF

BZLYF vs MRK: Complete Analysis 2026

BZLYFStock

Beazley plc provides risk insurance and reinsurance solutions in the United States, Europe, and internationally. Its Cyber & Executive Risk segment underwrites management liabilities, such as employment practices risks and directors and officers, cyber and technology, and media and business services. The company's Marine segment underwrites various marine classes, including hull, energy, cargo and specie, piracy, satellite, aviation, kidnap and ransom, and war risks. Its Market Facilities segment underwrites portfolios of businesses. The company's Political, Accident & Contingency segment underwrites terrorism, political violence, expropriation, and credit risks, as well as contingency and risks associated with contract frustration. This segment also underwrites life, health, personal accident, sports, and income protection risks. Its Property segment provides commercial and homeowners' insurance. The company's Reinsurance segment specializes in writing property catastrophe, property per risk, casualty clash, aggregate excess of loss, and pro-rata businesses. Its Specialty Lines segment underwrites a portfolio of businesses comprising architects and engineers, healthcare, lawyers and environmental liability, market facilities business, and international financial institutions. The company was founded in 1986 and is based in London, the United Kingdom.

Full BZLYF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BZLYF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BZLYF vs SCHDBZLYF vs JEPIBZLYF vs OBZLYF vs KOBZLYF vs MAINBZLYF vs JNJBZLYF vs ABBVBZLYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.